Ireland - English - HPRA (Health Products Regulatory Authority)

claris lifesciences (uk) limited - linezolid - solution for infusion - 2 mg/ml - other antibacterials

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - linezolid - granule, for suspension - 20 mg/ml - linezolid 20 mg/ml

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - linezolid - tablet, film coated - 600 mg - linezolid 600 mg

Ireland - English - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - linezolid - film coated tablet - 600 milligram - other antibacterials - other antibacterials - nosocomial pneumonia community acquired pneumonia indicated for the treatment of community acquired pneumonia and nosocomial pneumonia when known or suspected to be caused by susceptible gram positive bacteria. in determining whether linezolid is an appropriate treatment, the results of microbiological tests or information on the prevalence of resistance to antibacterial agents among gram positive bacteria should be taken into consideration.

United Kingdom - English - myHealthbox

infomed fluids - linezolid - solution for infusion - 2mg/ml - other antibacterials - it is indicated in adults for the treatment of community acquired pneumonia and nosocomial pneumonia when known or suspected to be caused by susceptible gram-positive bacteria. in determining whether linezolid 2 mg/ml solution for infusion is an appropriate treatment, the results of microbiological tests or information on the prevalence of resistance to antibacterial agents among grampositive bacteria should be taken into consideration. (see section 5.1 for the appropriate organisms).

United Kingdom - English - myHealthbox

actavis group ptc ehf - linezolid - film-coated tablets - 600mg - other antibacterials - nosocomial pneumonia community acquired pneumonia linezolid is indicated for the treatment of community acquired pneumonia and nosocomial pneumonia when known or suspected to be caused by susceptible gram positive bacteria. in determining whether linezolid is an appropriate treatment, the results of microbiological tests or information on the prevalence of resistance to antibacterial agents among gram positive bacteria should be taken into consideration. (see section 5.1 for the appropriate organisms). linezolid is not active against infections caused by gram negative pathogens. specific therapy against gram negative organisms must be initiated concomitantly if a gram negative pathogen is documented or suspected.

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - linezolid - solution for infusion - 2 mg/ml - other antibacterials

Ireland - English - HPRA (Health Products Regulatory Authority)

cipla (eu) limited - linezolid (form ii) - film coated tablet - 600 milligram - other antibacterials

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - linezolid - film coated tablet - 600 milligram - other antibacterials

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

actavis uk ltd - linezolid - oral tablet - 600mg